BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 35 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,138,650 | +23.4% | 1,500,000 | 0.0% | 0.03% | +28.0% |
| Q2 2023 | $922,573 | -3.5% | 1,500,000 | 0.0% | 0.02% | -3.8% |
| Q1 2023 | $956,261 | -17.2% | 1,500,000 | -50.0% | 0.03% | -16.1% |
| Q4 2022 | $1,155,000 | -13.2% | 3,000,000 | 0.0% | 0.03% | -18.4% |
| Q3 2022 | $1,331,000 | +5.4% | 3,000,000 | 0.0% | 0.04% | +11.8% |
| Q2 2022 | $1,263,000 | -11.6% | 3,000,000 | 0.0% | 0.03% | +3.0% |
| Q1 2022 | $1,429,000 | – | 3,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INHERENT GROUP, LP | 39,500,000 | $19,370,000 | 3.63% |
| Athyrium Capital Management, LP | 20,000,000 | $9,682,000 | 3.44% |
| Diameter Capital Partners LP | 65,894,000 | $31,800,000 | 1.48% |
| Affinity Asset Advisors, LLC | 10,000,000 | $4,680,000 | 0.75% |
| Context Capital Management, LLC | 22,958 | $11,209,000 | 0.73% |
| DeepCurrents Investment Group LLC | 39,355,000 | $18,879,000 | 0.59% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,000,000 | $2,373,000 | 0.53% |
| Aequim Alternative Investments LP | 35,000,000 | $16,380,000 | 0.43% |
| Antara Capital LP | 25,750,000 | $12,246,000 | 0.37% |
| ARISTEIA CAPITAL, L.L.C. | 31,816,000 | $15,472,000 | 0.28% |